Singapore's Sea beat Wall Street expectations for first-quarter revenue on Tuesday, driven by strong spending on its ecommerce platform amid growing competition in Southeast Asia, sending its U.S.-listed shares up 10.9% in morning trading.

Harmonic reported its first quarter 2026 results, delivering a substantial beat on both the top and bottom lines that sent shares surging 9.6% in morning trading, reflecting investor enthusiasm for the company's accelerating broadband revenue growth and an upward revision to its full-year outlook.

Plug Power reported its first-quarter results for 2026, beating Wall Street’s top- and bottom-line estimates and sending shares up 3.7% in morning trading. The company posted revenue of $163.5 million, a 22% increase year-over-year, which came in ahead of the consensus analyst estimate of approximately $144 million. On an adjusted basis, Plug Power reported a loss per share of ($0.08), narrower than the ($0.0963) loss that analysts had expected and a significant improvement from the ($0.17) adjusted loss reported in the same quarter a year ago.

Rigetti Computing shares fell 1.8% in morning trading after the quantum computing firm reported first-quarter results that were largely in line with Wall Street's estimates.

CleanSpark stock fell 2.3% in morning trading after the bitcoin mining and data center developer company delivered fiscal Q2 results that missed the consensus estimates by a wide margin.

MARA Holdings shares dropped 4.7% in morning trading as the digital infrastructure company reported first-quarter earnings that fell short of analyst expectations due to a loss related to the fair value of digital assets.

AST SpaceMobile shares fell 6.4% in morning trading following the release of its first-quarter financial results. The satellite designer reported a loss that significantly exceeded Wall Street expectations, overshadowing news of regulatory progress and upcoming launch milestones.

Hims & Hers Health missed Wall Street estimates for first-quarter revenue and posted a surprise loss, ​as the telehealth company's shift toward branded GLP-1 weight-loss drugs pressured its margins and domestic sales. Shares of the ‌company fell sank 12.9% in morning trading.

Under Armour forecast another annual revenue decline and expects profit well below estimates on Tuesday, as weakness in its key North American market weighs on CEO Kevin Plank's turnaround efforts. The shares fell about 20% in morning trading.